logo
#

Latest news with #ketaminetherapy

Human Touch Behavioral Health Introduces Intravenous Ketamine Therapy for Mental Health Treatment
Human Touch Behavioral Health Introduces Intravenous Ketamine Therapy for Mental Health Treatment

Globe and Mail

time23-06-2025

  • Health
  • Globe and Mail

Human Touch Behavioral Health Introduces Intravenous Ketamine Therapy for Mental Health Treatment

Human Touch Behavioral Health announces the launch of a new intravenous ketamine therapy service to support patients with treatment-resistant mental health conditions. Human Touch Behavioral Health has announced the official launch of its new intravenous ketamine therapy service, a medical treatment now available to patients dealing with depression, anxiety, PTSD, and other treatment-resistant mental health conditions. The program is now open for consultation and intake at its Sacramento clinic. This new offering marks a significant development in the organization's commitment to providing comprehensive and evidence-based mental health care. Administered under the supervision of licensed medical professionals in a controlled clinical setting, intravenous (IV) ketamine therapy has gained growing recognition within psychiatric medicine for its rapid-acting effects in patients who have not responded to traditional treatment methods. 'Our goal has always been to improve access to innovative and effective therapies,' said Dr. Archana Trivedi, Founder and CEO of Human Touch Behavioral Health. 'With the addition of IV ketamine therapy, we're expanding treatment options for individuals facing complex mental health challenges who deserve alternative pathways to relief.' The ketamine treatment protocol at Human Touch Behavioral Health includes a full psychiatric evaluation, customized treatment planning, medical monitoring, and counselling. Sessions take place in a calm and supportive environment designed to promote safety and healing. Human Touch Behavioral Health is a mental health provider offering a range of services, including individual and group therapy, psychiatric medication management, electro-convulsive therapy, transcranial magnetic stimulation, and now, ketamine therapy. The clinic is known for its multidisciplinary approach to patient care, with an emphasis on individualized treatment plans, trauma-informed practices, and a commitment to ethical, research-supported methods. The new ketamine program is now accepting referrals and new patient consultations. Eligibility for IV ketamine therapy is determined through a comprehensive clinical assessment by the Human Touch Behavioral Health care team. For more information on intravenous ketamine therapy or to schedule a consultation, visit or contact Human Touch Behavioral Health directly by calling us at: (916) 359-2950. Media Inquiries For interviews, media kits, or press opportunities, please contact: Rachel Magallanes Office ManagerHuman Touch Behavioral Health info@ | (916) 359-2950 About Human Touch Behavioral Health Human Touch Behavioral Health is a forward-thinking mental health practice dedicated to empowering individuals through innovative, personalized, and compassionate care. Founded by Dr. Archana Trivedi, Human Touch Behavioral Health continues to lead the charge in redefining psychiatric treatment for the modern era. Media Contact Company Name: Human Touch Behavioral Health, CLL Contact Person: Dr. Archana Trivedi Email: Send Email Phone: (916) 359-2950 Country: United States Website:

'I have a life back': How ketamine therapy is helping these Nova Scotians find relief from depression
'I have a life back': How ketamine therapy is helping these Nova Scotians find relief from depression

CBC

time03-06-2025

  • Business
  • CBC

'I have a life back': How ketamine therapy is helping these Nova Scotians find relief from depression

For decades, Sherri Topple's world was overshadowed by the crushing weight of depression that no medication or therapy seemed to fix. It wasn't until she tried ketamine therapy that she finally felt a sense of relief. At her worst, the Nova Scotia woman says she could barely muster up the energy to take a shower. "You look at the shampoo bottle and think, 'It's just too far. I can't reach,'" said Topple. "So you stand there with the water running and cry and think, 'What the heck is wrong with me?'" But after completing a clinical trial through Dalhousie University and receiving five doses of ketamine back in January, she said everything changed. "I have a life back. I have a better life back than what I've ever had," said Topple, who now enjoys painting, gardening and writing — hobbies she wasn't capable of while she was severely depressed. Ketamine is a fast-acting anesthetic used in medical or veterinary surgery. Selling, possessing or producing it in Canada is illegal unless it's authorized for medical or scientific purposes. In more recent years, it's become a tool used to treat severe depression that's been otherwise untreatable. Approximately 20 patients in the province have received ketamine therapy since March 2023, according to Nova Scotia's health authority. Psychiatrist Dr. Abraham Nunes runs the program through the mood disorders clinic at the QEII Health Sciences Centre, but can only administer the infusions on a compassionate basis due to limited resources and funding. Nunes has witnessed first-hand how ketamine therapy has improved the lives of patients like Topple. "It's quite remarkable how it can work, even for people who've been depressed for so long. But it helps them feel so much better that it actually provides them with hope that there is something that can be done," said Nunes. But some might think of ketamine as a club drug that's often used and abused for its hallucinogenic effects. "If you are buying ketamine off the street, using it in an uncontrolled fashion, or if I were to just give people vials of ketamine to take, that would of course be, yeah, a horror story," he said. A medical examiner ruled that ketamine was the primary cause of actor Matthew Perry's death. Perry was using the drug legally through his regular doctor, but he began seeking more ketamine than his doctor would give him and buying it illegally, eventually suffering a fatal overdose in 2023. Nunes says the drug is "very safe" when used at a low dose in a medically supervised environment. Because the treatment is not publicly funded in Nova Scotia, Nunes and a handful of other health-care professionals volunteer their time to treat one patient every two weeks. He said the QEII Foundation is currently raising funds to hire two nurses and some administrative staff in order to expand the program, and administer about eight treatments per day for two years as a pilot project. He said from there, they would evaluate the data and seek more stable funding from the government. CBC News asked the Department of Health and Wellness whether it's considering funding ketamine therapy for treatment-resistant depression. In a statement, the department responded that it regularly reviews the procedures and services covered by MSI, Nova Scotia's insurance system, but there are "no plans currently to include ketamine infusion treatment as an insured procedure or ketamine as a benefit under the Nova Scotia Pharmacare Program." Patients like Lisa Herritt could benefit from ketamine therapy becoming part of Nova Scotia's public health system. She was also treated by Nunes, but unlike Topple, Herritt requires infusions on a more regular basis and had to seek treatment beyond what's being offered through the QEII Foundation. She was ultimately referred to a private clinic where she receives ketamine infusions every other week to the tune of $12,000 per year. Although it's expensive, she says going without the treatment is not an option for her. "I feel like I know what would happen, and I would go right back to where I was. And it is a horrible place," said Herritt, who has suffered from depression for more than 22 years since the birth of her first son. She said prior to receiving ketamine, her depression was "insurmountable." Herritt was disengaged from her children's lives and she eventually had to leave her 20-year career as a pharmacist. Herritt had tried many different medications to get her depression under control to no avail. She even tried electroconvulsive therapy until turning to ketamine as a last resort in 2023. She has responded well to the drug and believes that ketamine therapy should be made more accessible to Nova Scotians suffering with the mental illness. "If there's a treatment out there that would work after multiple failures, why wouldn't we do it for people? It's not like you wouldn't treat other illnesses that there's a treatment for," she said. Topple agrees. "Nova Scotians need this … and it needs to be funded. It will save so much pain, so much hurt and it will save a lot of money in unnecessary health care," she said.

Episode 2: Donovan: Childhood Sexual Abuse
Episode 2: Donovan: Childhood Sexual Abuse

CBC

time12-05-2025

  • Entertainment
  • CBC

Episode 2: Donovan: Childhood Sexual Abuse

Donovan has lived in fear and anger ever since he told the truth about being abused by his mother's boyfriend and then felt betrayed by social workers who were supposed to help. Now, after several ketamine therapy sessions, Donovan can finally look back upon his child-self with care and calm and works to become the kind of adult he needed for his own children. Hillary makes a bad move in treating him and faces the mistake. New episodes will be released weekly on Mondays. Don't want to wait? Binge the whole season right now via CBC Stories Premium [ on Apple Podcasts.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store